2009年9月考入华中科技大学同济药学院，攻读药学专业，2013年6月本科毕业并获得理学学士学位。
2013年9月保送至清华大学药学系攻读生物学（药剂学）博士，2016年转入药学院至今。
研究方向：抗肿瘤药物纳米递送及体内外评估
个人邮箱：kc13@mails.tsinghua.edu.cn
发表的学术论文
1. Chao Kong, Yang Li, Zhengsheng Liu, Junxiao Ye, Zhaohui Wang, Ling Zhang, Weijian Kong, Huiqin Liu, Chun Liu, Huanhuan Pang, Zeping Hu, Jinming Gao, and Feng Qian* (2019). Targeting the oncogene KRAS-mutant pancreatic cancer by synergistic blocking of lysosomal acidification and rapid drug release. ACS Nano 4, 4049-4063.
2. Chao Kong#, Junxiao Ye#, Zhengsheng Liu, Weijian Kong, Mengnan Sun, Huiqin Liu, Fang Yuan, Feng Qian. Improved intratumor drug delivery and therapeutic efficacy in pancreatic cancer by albumin-Cisplatin complex [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, Georgia: AACR; Cancer Res 2019. (#co-first author)
3. Lei Liu#, Chao Kong#, Meng Huo, Chengyu Liu, Liao Peng, Tian Zhao, Yen Wei, Feng Qian* and Jinying Yuan* (2018). Schiff base interaction tuned mesoporous organosilica nanoplatforms with pH-responsive degradability for efficient anti-cancer drug delivery in vivo. Chemical Communications 54, 9190-9193. (#co-first author)
4. Chun Liu, Chao Kong, Guoliang Wu, Junhao Zhu, Babak Javid, Feng Qian *. (2015). Uniform and amorphous rifampicin microspheres obtained by freezing induced LLPS during lyophilization. International journal of pharmaceutics 495, 500-507.
5. Ling Zhang, Zhengsheng Liu, Chao Kong, Chun Liu, Kuan Yang, Huijun Chen, Jinfeng Huang, Feng Qian* (2018). Improving Drug Delivery of Micellar Paclitaxel against Non-Small Cell Lung Cancer by Coloading Itraconazole as a Micelle Stabilizer and a Tumor Vascular Manipulator. Small 0, 1802112.
6. Huiqin Liu, Mengnan Sun, Zhengsheng Liu, Chao Kong, Weijian Kong, Junxiao Ye, Jianan Gong, David C.S. Huang, Feng Qian* (2019). KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs. Journal of Controlled Release 296, 40-53.